17 May 2016 - Company details discounts of up to 40% to hospitals for Nitropress and Isuprel.

Valeant Pharmaceuticals International Inc. said Monday that it would expand discounts for a pair of its heart drugs following heavy scrutiny over its pricing tactics.

Under the changes, effective immediately, hospitals are eligible for a rebate of at least 10% but up to 40% based on the volume of drugs bought during a quarter. The program covers cardiac-care drugs Nitropress and Isuprel.

For more details, go to: http://www.wsj.com/articles/valeant-outlines-heart-drug-discounts-after-heavy-scrutiny-1463402446